Curaleaf
Curaleaf
Curaleaf Holdings, Inc. is an international cannabis company that cultivates, manufactures, distributes, and sells cannabis products for medical and adult-use markets. Its portfolio includes flower, pre-rolls, vaporizer products, edibles, concentrates, topicals, tinctures, beverages, and other cannabis-related products. The company operates vertically integrated cultivation and manufacturing facilities, branded retail dispensaries, wholesale relationships, and international distribution channels.
Curaleaf developed through the consolidation and expansion of cannabis businesses across multiple U.S. states and international markets. As of December 31, 2025, Curaleaf operated in 14 U.S. states, maintained 168 owned and managed retail locations, served more than 1,300 wholesale partner accounts, and made its international products available to medical-cannabis patients in 15 countries. By August 2026, its U.S. retail network had expanded to approximately 175 to 176 owned and managed locations.
An important headquarters correction is required for older Massachusetts-based references. Curaleaf’s current SEC filings identify its principal executive offices at 250 Harbor Drive, Third Floor, Stamford, CT 06902, not Wakefield, Massachusetts. Curaleaf is incorporated in British Columbia, Canada, trades on the Toronto Stock Exchange under CURA, and is quoted on the OTCQX under CURLF. Current filings identify Boris Jordan as Chief Executive Officer and Ed Kremer as Chief Financial Officer.
Curaleaf Holdings, Inc.
250 Harbor Drive, Third Floor
Stamford, CT 06902
United States
This is Curaleaf’s current principal executive office according to its October 2026 SEC filings.
Curaleaf’s current principal corporate office is
250 Harbor Drive, Third Floor
Stamford, CT 06902
This address is used in current regulatory filings and U.S. securities documents.
Curaleaf’s current public filings use the Stamford corporate address above for principal corporate correspondence.
Individual cannabis dispensaries, cultivation operations, and regional businesses have separate addresses. Customers with store-specific concerns should contact the dispensary where the transaction occurred rather than mailing routine retail complaints directly to headquarters.
Older Curaleaf information has associated the company with Massachusetts, including Wakefield-area corporate operations. Those references should not be used as the current principal headquarters. The verified current principal executive office is in Stamford, Connecticut.
917-717-5875
Curaleaf’s current SEC filings list this as the registrant’s telephone number.
Curaleaf does not publish one universal nationwide customer-service number for all dispensaries.Customers should contact the specific Curaleaf dispensary associated with their purchase or use Curaleaf’s location-specific digital support channels.
250 Harbor Drive, Third Floor, Stamford, CT 06902
250 Harbor Drive, Third Floor, Stamford, CT 06902
Investor Relations: IR@curaleaf.com
Curaleaf does not prominently publish a single nationwide consumer-support email that replaces local dispensary support.
Cannabis, Medical Cannabis, Adult-Use Cannabis, Cultivation, Manufacturing, Retail and Consumer Packaged Goods
Curaleaf’s current public materials emphasize the development of its modern cannabis platform rather than consistently using one simple consumer-facing founding date. The company operates through Curaleaf Holdings, Inc., incorporated in British Columbia, Canada.
5,554 employees as of December 31, 2025
This included 4,862 employees in the United States, 92 in Canada, 598 in Europe, and 2 in Australia.
Curaleaf operated 168 U.S. retail locations at December 31, 2025 and had expanded to approximately 175 to 176 locations by August 2026.
Curaleaf does not publish standard public walk-in hours for its Stamford headquarters.
Investor Relations
Careers
https://job-boards.greenhouse.io/curaleaf
Curaleaf sells cannabis flower in medical and adult-use markets where permitted by state or national law. Flower can vary by strain, cannabinoid profile, potency, terpene composition, package size, and brand.
Pre-rolls provide pre-measured cannabis flower in a ready-to-use format for eligible adult or medical consumers. Curaleaf’s brand portfolio includes products positioned across value, mainstream, and premium segments.
Curaleaf manufactures and sells cannabis vaporizer cartridges and related products in regulated markets. Products can vary in cannabinoid profile, flavor, formulation, hardware compatibility, and potency.
Curaleaf’s edible portfolio includes products such as gummies and other ingestible cannabis formats. JAMS and other company brands participate in this category, with formulations and product availability varying by jurisdiction.
Cannabis concentrates are available in selected markets under Curaleaf and affiliated brands. These products contain concentrated cannabinoids and are sold only where permitted under local cannabis regulations.
Tinctures provide measured cannabis extracts intended for oral or sublingual use. They are often offered within medical markets where patients or consumers want alternatives to inhaled products.
Topical cannabis products can include creams, lotions, balms, and other formulations intended for external use. Exact products and cannabinoid compositions vary by market.
Curaleaf’s portfolio includes beverage products in certain regulated jurisdictions. Beverage availability depends on local laws, market approval, and product distribution.
Curaleaf operates branded retail dispensaries where eligible medical patients and adult-use consumers can purchase approved cannabis products. Stores also carry qualifying third-party products in addition to Curaleaf-owned brands.
Select is one of Curaleaf’s prominent cannabis brands and is especially associated with vapor and other consumer cannabis products. It is distributed through Curaleaf stores and wholesale channels in qualifying markets.
Grassroots is a Curaleaf brand offering cannabis flower and other products positioned toward quality-focused consumers. Availability differs by state and local licensing rules.
Find is a Curaleaf cannabis brand positioned around accessible flower and related products. It participates in the company’s broader good, better, best brand architecture.
JAMS is part of Curaleaf’s edible and lifestyle cannabis portfolio. Products can include gummies and other formats designed for regulated adult-use markets.
Dark Heart is part of Curaleaf’s expanded brand portfolio. Its exact retail availability and product selection vary by jurisdiction.
Anthem is another current Curaleaf portfolio brand cited in recent company disclosures. Product availability depends on market and regulatory approval.
Curaleaf supplies company-owned brands to third-party cannabis retailers through wholesale relationships. At the end of 2025, the company reported more than 1,300 wholesale partner accounts in the United States.
Curaleaf International distributes medical cannabis products through pharmacies, clinics, telemedicine channels, and other regulated healthcare routes in Europe and additional international markets. Its international footprint includes the United Kingdom, Germany, Poland, Canada, and Australasia.
Curaleaf operates vertically integrated cultivation facilities that produce cannabis for company brands and retail operations. At the end of 2025, the company reported 17 cultivation sites with approximately 1.5 million square feet of cultivation capacity.
Curaleaf processes cannabis into manufactured products such as concentrates, oils, vapes, edibles, tinctures, and other formats. Manufacturing is performed under applicable state or national cannabis regulations.
917-717-5875.
917-717-5875
917-717-5875
917-717-5875
No single universal nationwide Curaleaf customer-service number is publicly verified.
Customers should use the local dispensary number for the store involved.
Curaleaf customer support is generally decentralized by store, state, and market.
Curaleaf does not prominently publish a universal toll-free consumer support number.
Retail purchases are handled through individual dispensaries and local ordering systems rather than a central telephone sales department.
No universal public billing number is listed.
Payment disputes should begin with the dispensary involved.
Regional operating contacts vary by state and business unit.
Each Curaleaf dispensary has its own local contact information.
Curaleaf International uses country-specific operations and local support routes rather than one universal international customer-service number.
Curaleaf does not publish a nationwide consumer emergency hotline.Medical emergencies should be directed to emergency medical services.
Curaleaf’s recent public disclosures emphasize email contact
IR@curaleaf.com
A permanent dedicated IR telephone number is not prominently listed in the current disclosure cited here.
For the specific 2026 shareholder process disclosed by Curaleaf
1-800-530-5189 North American toll-free
416-751-2066 outside North America, collect
These contacts were provided through Carson Proxy Advisors for that shareholder process and should not be treated as general retail customer support.
No permanent universal media phone is prominently published.
Kekst-Curaleaf@kekstcnc.com.
No universal public applicant HR number is listed.
https://job-boards.greenhouse.io/curaleaf
Not applicable.
For a retail complaint, the fastest route is normally the dispensary where the purchase occurred. Curaleaf’s operations are regulated state by state, and dispensary teams are best positioned to verify receipts, product batch information, pickup orders, loyalty activity, inventory, refunds where permitted, and local cannabis-regulation requirements. Have your receipt, order number, store location, purchase date, and product packaging available.
For a serious product concern, keep the original packaging, batch or lot information, product label, photographs, and proof of purchase. Do not dispose of a product that may be needed for quality investigation unless a regulator or health professional advises otherwise. If the issue involves a corporate, investor, or securities matter rather than a dispensary purchase, Curaleaf’s current principal office is available at 917-717-5875, while Investor Relations can be reached through IR@curaleaf.com.
Because cannabis regulations vary significantly between jurisdictions, a store may need to follow state-specific procedures for returns, defective products, medical-program issues, potency questions, adverse events, recalls, or complaints. Customers should therefore begin locally before escalating to Curaleaf headquarters or a cannabis regulator.
Complaints can involve product quality, incorrect orders, dispensary service, billing, medical-program access, packaging, product labeling, loyalty programs, employee conduct, privacy, or other regulated cannabis matters. Before escalating, gather your receipt, product packaging, lot or batch number, store location, purchase date, photographs, medical-cannabis documentation where relevant, and any previous communication.
Begin with the Curaleaf dispensary where the transaction occurred. Ask for the appropriate store representative and provide the order number, purchase date, product name, batch information, and a clear explanation of the complaint. For quality concerns, keep the package and label because regulated cannabis products can often be traced through batch and production records.
If the issue is product-specific, ask the store to route it to the appropriate quality, compliance, retail operations, or product team. Medical-cannabis concerns may also require interaction with the store’s medical-program support process. Employee, accessibility, privacy, or delivery complaints should be directed to the relevant specialized team rather than handled only as a standard retail issue.
Ask for review by a dispensary manager, regional manager, or appropriate management representative if the first-level response is inadequate. Provide the full timeline, previous employee contacts, photographs, batch information, and the exact resolution being requested. Because cannabis products are highly regulated, some issues may require formal internal documentation before a refund, replacement, recall review, or other action can be approved.
Use the relevant Curaleaf website contact or store-support channel to create a written record. Written complaints are especially useful when the issue involves packaging, labeling, adverse reactions, delivery, product defects, or disputed transactions. Include the store address, state, date, product brand, lot information, and prior complaint history.
For an unresolved serious matter, write to Curaleaf Holdings, Inc., 250 Harbor Drive, Third Floor, Stamford, CT 06902. Include your contact details, store location, state, product information, previous escalation history, and copies of supporting records. The Stamford address is the current verified principal executive office.
Certain complaints require specialized handling. Product-quality issues may need Curaleaf’s quality or compliance teams, investor matters should use IR@curaleaf.com, and shareholder-process questions should use the contact designated for the specific transaction. Employment complaints should use the company’s HR or ethics processes rather than dispensary customer service.
Cannabis regulation is primarily state-based in the United States. Product, dispensary, licensing, testing, labeling, or medical-program complaints may be filed with the cannabis-control agency responsible for the state where the sale occurred. The exact regulator can be a cannabis control commission, department of health, liquor and cannabis board, or other state agency depending on jurisdiction.
For ordinary payment or consumer issues, customers can also use the appropriate state Attorney General or consumer-protection agency where legally applicable. Card-payment disputes may be raised with the payment provider or bank, subject to cannabis-business payment rules and the actual transaction method used. Keep receipts, screenshots, and the company’s response before filing externally.
If a significant dispute remains unresolved, review the transaction terms, website terms, loyalty-program terms, privacy terms, and any arbitration provisions that apply. Cannabis law can involve overlapping state and federal rules, so legal advice may be appropriate for serious claims involving injury, regulatory compliance, employment, commercial contracts, or substantial financial loss.
Ramona Tire is an automotive service company that provides a wide range of tire and…
Car-X Tire & Auto is a well-known automotive service chain in the United States, specializing…
Curo Financial Technologies Corp. is a company that provides a range of financial services, primarily…
Enova International, Inc. is a financial technology (fintech) company that provides online financial services to…
Community Choice Financial Inc. (CCFI) is a financial services company that provides a variety of…
Smile Brands Inc. is a leading provider of business support services to dental practices in…
This website uses cookies.